Clinical Trials Browser

Phase 2 × vandetanib × Gynecologic × Clear all

NCT00872989 2016-12-19

S0904: Docetaxel With or Without Vandetanib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Phase 2 Completed

129 enrolled 17 charts

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00445549 2012-06-26

Vandetanib to Treat Women With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Phase 2 Terminated

12 enrolled 5 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms